Evaluation for withdrawal symptoms following chronic zomepirac administration.
D000700:Analgesics / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D011795:Surveys and Questionnaires; D014046:Tolmetin / Q000009:adverse effects* / Q000031:analogs & derivatives
D000700:Analgesics; D011758:Pyrroles; C020549:zomepirac; D014046:Tolmetin; D001241:Aspirin